Altamira Therapeutics Ltd. Total Assets
Altamira Therapeutics Ltd. (CYTOF) had Total Assets of $7.13 million as of 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Notes
ifrs-full:Assets · last filed 2025-08-29
- 2023-12-31: Assets 7.69M CHF.
- 2023-06-30: Assets 6.20M CHF.
- 2022-12-31: Assets 6.30M CHF.
- 2022-06-30: Assets 18.48M CHF.
CHF
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2023-12-31 | 7.69M CHF 20-F/A · filed 2024-04-22 | |
| 2023-06-30 | 6.20M CHF 6-K · filed 2023-09-12 | |
| 2022-12-31 | 6.30M CHF 20-F/A · filed 2024-04-22 | |
| 2022-06-30 | 18.48M CHF 6-K/A · filed 2023-08-21 | |
| 2021-12-31 | 19.17M CHF 6-K/A · filed 2023-08-21 | 18.84M CHF 20-F · filed 2022-04-12 |
| 2021-06-30 | 23.73M CHF 6-K · filed 2021-09-08 | |
| 2020-12-31 | 20.80M CHF 20-F · filed 2022-04-12 | |
| 2020-06-30 | 7.96M CHF 6-K/A · filed 2020-09-17 | |
| 2019-12-31 | 9.23M CHF 20-F · filed 2021-03-31 | |
| 2019-06-30 | 11.73M CHF 6-K · filed 2019-08-15 | |
| 2018-12-31 | 9.88M CHF 20-F · filed 2020-04-16 | |
| 2017-12-31 | 17.83M CHF 20-F · filed 2019-03-14 | |
| 2016-12-31 | 35.66M CHF 20-F · filed 2018-03-22 |
USD
| Period end | Assets |
|---|---|
| 2025-06-30 | $7.13M 6-K · filed 2025-08-29 |
| 2024-12-31 | $8.65M 6-K · filed 2025-08-29 |
| 2024-06-30 | $8.07M 6-K · filed 2024-09-24 |
| 2023-12-31 | $9.14M 20-F · filed 2025-04-30 |
| 2023-01-01 | $6.81M 20-F · filed 2025-04-30 |